期刊文献+

脂肪组织功能紊乱与胰岛素抵抗 被引量:3

暂未订购
导出
摘要 脂肪组织且前被视为一个高度活跃的代谢和内分泌器官。脂肪细胞可以通过自身聚脂对日常膳食的脂肪起缓冲作用.还能分泌各种脂肪因子而调节全身或局部的能量代谢。脂肪组织的功能紊乱时.机体可出现肥胖.并且有越来越多的证据表明.脂肪组织的功能障碍在胰岛素抵抗(insulin resistance.IR)的发生和进展中起着主要作用。
作者 张毅 刘精东
出处 《江西医药》 CAS 2010年第6期607-610,共4页 Jiangxi Medical Journal
  • 相关文献

参考文献21

  • 1Goossens GH.The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance.Physiol Behav,2003,9(4):206.
  • 2Xu H,Barnes GT,Yang Q,et al.Chronic inflammation in fat phys.a crucial role in the development of obesity-related insulin resistance.J Clin Invest,2003,112(12):1821.
  • 3Frayn KN,Karpe F,Fielding BA,et al..Integrative physiology of human adipose tissue.Int J Obes Relat Metab Disord.2003,27(8):875.
  • 4Hopfl G,Ogunshola O,Gassmann M.HIFs and tumors-causes and consequences.Am J Physiol Rngul Integr Comp Physiol,2004,286(4):6O8.
  • 5Lolmede K,Durand de Saint Front V,Galitzky J,et al.Effects of hypoxia on the expression of proangiogonic factors in differentiated 3T3-F442A adipocytes.Int J Obes Relat Metab Disord,2003,27(10):1187.
  • 6Hosogai N,Fukuhara A,Oshima K,et al.Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation.Diabetes,2007,.56(4):901.
  • 7Ye J,Gao Z,Yin J,et al.Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice.Am J Physiol Endecrinol Metab,2007,293(4):1118.
  • 8Bi M,Naczki C,Koritzinsky M,et al.ER stress regulated translation increases tolerance to extreme hypoxia and promotes tumor growth.EMBO J,2005,24(19):3470.
  • 9Fariss MW,Chan CB,Patel M,et al.Role of mitochondria in toxic oxidative stress.Mol Interv,2005,5.'94.
  • 10杨义生,陈家伦.脂肪组织分泌功能研究新进展[J].中国糖尿病杂志,2004,12(3):228-230. 被引量:14

二级参考文献43

  • 1王娟,李彩萍.胰岛素抵抗与2型糖尿病[J].医学综述,2005,11(6):511-513. 被引量:15
  • 2勾忠平,李秀钧.糖尿病属慢性炎症性疾病——慢性炎病新概念释义与讨论[J].实用糖尿病杂志,2007,3(2):5-7. 被引量:15
  • 3李焱.氧化应激与胰岛素抵抗及其对策[J].实用糖尿病杂志,2007,3(3):6-7. 被引量:8
  • 4Trayhurn P, Beattie JH. Physiological role of adipose tissue:white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc, 2001,60 : 329-339.
  • 5Yang YS, Song HD, Li RY, et al. The gene expression profiling of human visceral adipose tissue and its secretory functions.Biochem Biophys Res Commun, 2003,300 : 839-846.
  • 6Zastrow O, Seidel B, Kiess W, et al. The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data. Int J Obes Relat Metab Disord, 2003, 27: 1472-1478.
  • 7Wilsey J, Zolotukhin S, Prima V, et al. Central leptin gene therapy fails to overcome leptin resistance associated with dietinduced obesity. Am J Physiol Regul Integr Comp Physiol,2003,285 : R1011-R1020.
  • 8Shigemura N, Ohta R, Kusakabe Y, et al. Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures. Endocrinology, 2004,145 : 839-847.
  • 9Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature,2003,423:762-769.
  • 10Diez J J, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol, 2003,148 : 293-300.

共引文献25

同被引文献35

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部